Covalon claims US first for hydrated collagen silver dressing:
This article was originally published in Clinica
Covalon Technologies has received US approval to sell what it claims is the first hydrated collagen dressing with antimicrobial silver, CovaClear Ag. While silver ion is a broad-spectrum antiseptic that allows the dressing to be an effective antimicrobial barrier, a moist wound-healing environment is known to improve the healing process and reduce scarring, said the Mississauga, Ontario firm. The product is also transparent, allowing clinicians to monitor high-risk wounds without having to remove the dressing. CovaClear Ag is indicated for the management of full and partial thickness wounds. According to Covalon, the total US market for moist dressings (hydrocolloids/hydrogels) exceeds $500m per year.
You may also be interested in...
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.
Belgian developer of cancer diagnostics is building an infectious disease portfolio on the back of its new SARS-CoV-2 test and collaborations with Immunexpress and Endpoint Health.